Description
PRINCIPIO ACTIVO: CLOROQUINA FOSFATO
100 ML Crema Envase
un anticuerpo monoclonal inhibidor del factor de necrosis tumoral alfa (TNF-α)
No indicado en pacientes con hipoglucemia o hipersensibilidad conocida a los componentes
Controlar presión arterial regularmente durante el tratamiento
SENEX3 PVO SBR C30 CELGENE PRINCIPIO ACTIVO: CLOROQUINA FOSFATOPRINCIPIO ACTIVO: LACTOBACILLUS FORMA FARMACUTICA: 3 POLVO PRESENTACIN: 1 SOBRES
Exchange/Return Notes
- We offer a 30-day return/exchange service after receiving.
- Final sale items are not eligible for returns or exchanges.
- To process your return/exchange, please contact us at [email protected]
- Please click here for more details>>> Return & Exchange Policy
























